Drugs / TAP-144-SR(6M)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01546649 | Apr 2012 → Dec 2014 | breast carcinoma | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAP-144-SR(6M) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01546649 ↗ |
| Route | Other | “TAP-144-SR(6M) 22.5 mg, injection” NCT01546649 ↗ |